EB66 NTCC®疫苗和治疗性蛋白生产用鸭胚胎干细胞株duck embryonic stem cell-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

价　　格：¥1998950
货　　号：NTCC®-295 EB66
产　　地：北京

竭诚为您服务！

BioVector NTCC典型培养物保藏中心: 联系人：Dr.Xu, Biovector NTCC Inc.; 电话：400-800-2947 工作QQ:1843439339 (微信同号); 邮件：Biovector@163.com; 手机：18901268599; 地址：北京; 已注册

详细信息
咨询记录(共0条)

The NTCC® EB66 cell line is a duck embryonic stem cell-derived cell line that has been developed as a platform for the production of vaccines and therapeutic proteins. It is considered a valuable tool in the biotechnology industry due to its unique characteristics and advantages.

Key characteristics of the NTCC® EB66 cell line:

Origin: Derived from duck embryonic stem cells
Advantages:
- High growth rate: Short population doubling time, allowing for rapid cell expansion.
- High cell density: Can reach very high cell densities in culture, increasing production yields.
- Unique metabolic profile: Low ammonium and lactate accumulation, reducing the need for frequent media changes.
- Reduced fucose content: Leads to enhanced antibody-dependent cellular cytotoxicity (ADCC) activity of therapeutic antibodies produced in this cell line.
- Genetic stability: Maintained through the expression of telomerase, ensuring long-term culture stability.
- Scalability: Can be easily scaled up for industrial production in bioreactors.

Applications of the EB66 cell line:

Vaccine production: Used for the production of a variety of human and veterinary vaccines, including influenza, rabies, and Zika virus vaccines.
Therapeutic protein production: Used for the production of therapeutic antibodies and other recombinant proteins.

Advantages of using the EB66 cell line:

Consistent product quality: The use of a well-characterized cell line ensures consistent product quality and reproducibility.
Reduced production costs: The high growth rate and scalability of the EB66 cell line can lead to reduced production costs.
Enhanced product efficacy: The reduced fucose content of antibodies produced in EB66 cells can lead to enhanced ADCC activity, improving their therapeutic efficacy.

Overall, the NTCC® EB66 cell line is a valuable tool for the production of vaccines and therapeutic proteins. Its unique characteristics and advantages make it a promising platform for the development of new and improved biopharmaceuticals.

NTCC® EB66 细胞系是一种来源于鸭胚胎干细胞的细胞系，已被开发为生产疫苗和治疗性蛋白的平台。由于其独特的特性和优势，它被认为是生物技术行业中一种有价值的工具。

NTCC®EB66 细胞系的关键特征：

起源： 源自鸭胚胎干细胞
优势：
- 高生长速率： 细胞倍增时间短，可快速扩增细胞。
- 高细胞密度： 在培养中可达到非常高的细胞密度，从而提高产量。
- 独特的代谢特征： 氨和乳酸积累较少，减少了频繁更换培养基的需求。
- 降低岩藻糖含量： 导致在该细胞系中产生的治疗性抗体的抗体依赖性细胞毒性 (ADCC) 活性增强。
- 遗传稳定性： 通过端粒酶的表达维持，确保长期培养稳定性。
- 可扩展性： 可在生物反应器中轻松放大生产。